Kraig Biocraft Laboratories, Inc. (Trading Symbol: KBLB) is an innovative and aggressive biotechnology company focused on the development and commercialization of spider silk. Based on proprietary genetic engineering technology, Kraig Labs has successfully developed and produced next-generation polymers and protein-based fibers including recombinant spider silk. Our work has recently succeeded in creating and developing new fibers that have never been seen before with extraordinary properties of strength and flexibility. Our research arm remains focused on the continued development of new recombinant spider silks and other high strength polymers that we believe have the potential for significant industrial and consumer applications. —- February 16, 2021– Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company” or “Kraig Labs”), the biotechnology company focused on the development and commercialization of spider silk, announces that the Company has filed a patent application protecting its most advanced knock-in knock-out gene editing technologies for the creation of nearly pure spider silk. Entitled “Modification of Heavy Chain Fibrion in Bombyx Mori“, this patent covering the core technologies the Company has developed for the mass production of nearly pure spider silk fibers.

Learn more (opens external site)

 

Comments are closed.

Submit a Team Connection

Click here to submit a new Bioinspired Design Connection (you must be logged in first).

Browse Team Connections

Choose by category, team or week:

BioDesign Connections by Category (2020 – 2022)

by Team (2022 only)

by Week (2022 only)

Most Recent Connections

Connection Interactions

Recent Comments

  1. to reduce the impact of car accidents, it may be possible to study the force diverting physics of cockroaches to…

Top Voted Connections